InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
6
T+90 hit rate
0%
T+90 mean return
-10.8%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Power Sean A, Chief Financial Officer. Director active across 1 company, notably TG Therapeutics, INC.. In total, 12 reports have been published. Split: 0 buy · 6 sells. Total volume traded: €5.5m. Activity tracked since 18 June 2021. The latest transaction was filed on 29 January 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations12 total
87,500 shares0Common StockSEC:0001437749-25-002290:0
11,337 shares@ US$30.2946.1% of flowCommon StockSEC:0001437749-25-000662:0
47,867 shares@ US$16.9113.5% of flowCommon StockSEC:0001437749-24-000756:0
73,647 shares@ US$26.7033.5% of flowCOMMON STOCKSEC:0001104659-23-068182:0
85,000 shares0COMMON STOCKSEC:0001104659-23-032338:0
75,000 shares0Common StockSEC:0001104659-22-082024:0
75,312 shares@ US$19.2023.4% of flowCOMMON STOCKSEC:0001104659-22-002361
75,312 shares@ US$19.200.021% mcap50.0% of flowCOMMON STOCKSEC:0001104659-22-002361:0
25,000 shares0COMMON STOCKSEC:0001104659-21-084262:0
25,000 shares0COMMON STOCKSEC:0001104659-21-084262
22,790 sharesCOMMON STOCKSEC:0001144204-16-074714:0
50,000 sharesCOMMON STOCKSEC:0001144204-16-073862:0
12 of 12 declarations
About Power Sean A
Sean A. Power is the Chief Financial Officer, Secretary, and Treasurer of TG THERAPEUTICS, INC. In this role, he is responsible for financial management and strategy for the company. TG THERAPEUTICS, INC. is a biopharmaceutical company focused on developing treatments for serious diseases. Sean plays a key role in financial planning and analysis.
